Clinical Trial Update: Safety and Efficacy Study of AVI-5126 When Used on Vein Grafts Before Use in Heart by-Pass Graft Surgery (CABG) [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy study of AVI-5126 used on vein grafts in coronary artery bypass graft (CABG) surgery has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease

Drugs mentioned

• AVI-5126

Snippet

Sponsor: Sarepta Therapeutics, Inc. | Conditions: Cardiovascular Disease, Coronary Artery Bypass | Phase 2 | Status: TERMINATED